3T Biosciences, an immunotherapy company, has appointed Rebeca Villarreal-Barragan, MBA, as head of clinical operations where she will lead all aspects of clinical operations as the company advances its pipeline of T-cell receptor (TCR)-based therapeutics for solid tumors. “Rebeca brings a strong track record of building and leading clinical operations in both established biopharma organizations and emerging biotechnology companies,” said Behzad Kharabi, M.D., Chief Medical Officer of 3T Bios...